SNCA and Parkinson disease: Since studies have shown dysfunction of the MAPK protein in PD [8], we analyzed the effects of osmotin on MAPK-associated pathways and investigated the expression of p-p38, p-JNK, and p-ERK in MPTP/α-synuclein-induced models in vivo and in vitro.